首页> 外文OA文献 >Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

【2h】

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸可改善亨廷顿舞蹈症小鼠模型的运动功能障碍

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hockly, Emma; Richon, Victoria M.; Woodman, Benjamin; Smith, Donna L.; Zhou, Xianbo; Rosa, Eddie; Sathasivam, Kirupa; Ghazi-Noori, Shabnam; Mahal, Amarbirpal; Lowden, Philip A. S.; Steffan, Joan S.; Marsh, J. Lawrence; Thompson, Leslie M.; Lewis, Cathryn M.; Marks, Paul A.; Bates, Gillian P.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 en_US
中图分类

相似文献

外文文献
中文文献
专利

1. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. [J] . Hockly E, Richon VM, Woodman B, Proceedings of the National Academy of Sciences of the United States of America . 2003,第4期

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸可改善亨廷顿舞蹈症小鼠模型的运动功能障碍。
2. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model [J] . Markus Thiemann, Susanne Oertel, Volker Ehemann, Radiation oncology . 2012,第1期

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸联合放疗在恶性横纹肌瘤小鼠模型中的体内疗效
3. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model [J] . Markus Thiemann, Susanne Oertel, Volker Ehemann, Radiation oncology . 2012,第1期

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸联合放疗在恶性横纹肌瘤小鼠模型中的体内疗效
4. In silico modification of Zn~(2+) binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds as Homo sapiens class II HDAC inhibitor of cervical cancer [C] . Usman Sumo Friend Tambunan, Ridla Bakri, Arli Aditya Parikesit Joint Conference on Chemisty . 2016

机译：通过有机烯化合物作为Zn〜（2+）结合基团的Zn〜（2+）结合基团的Zn〜（2+）结合基团的组织化合物作为宫颈癌的HOMO SAPIENS II HDAC抑制剂
5. The structural requirements of histone deacetylase (HDAC) inhibitors: Suberoylanilide hydroxamic acid (SAHA) analogues modified at C3, C6, and C7 positions enhance selectivity [D] . Choi, Sun Ea 2012

机译：组蛋白脱乙酰基酶（HDAC）抑制剂的结构要求：在C3，C6和C7位置修饰的Suberoylanilide异羟肟酸（SAHA）类似物可提高选择性
6. Suberoylanilide hydroxamic acid a histone deacetylase inhibitor ameliorates motor deficits in a mouse model of Huntingtons disease [O] . Emma Hockly, Victoria M. Richon, Benjamin Woodman, 2003

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸可改善亨廷顿舞蹈症小鼠模型的运动功能障碍
7. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease [O] . Hockly, Emma, Richon, Victoria M., Woodman, Benjamin, 2003

机译：组蛋白脱乙酰基酶抑制剂Suberoylanilide异羟肟酸可改善亨廷顿舞蹈症小鼠模型的运动功能障碍

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

著录项

引文网络

相似文献

相关主题

期刊订阅